Filing Flows › Mesa Laboratories (MLAB) › Q1 FY27 › vs Q4 FY26
Mesa Laboratories (MLAB) Q1 FY27 vs Q4 FY26 (quarter over quarter)
Mesa Laboratories's revenue fell $3.6M (-6%) from $63.7M in Q4 FY26 to $60.1M in Q1 FY27. Gross margin 64.9% against 66.2% (-1.4 pts).
Mesa Laboratories, Q1 FY27: revenue $60.1M (+1% year over year), operating margin 11.7%, net earnings $2.8M, operating cash flow $14.7M. The chart draws each line against Q4 FY26, the increases inside each band.
Margins
| Q1 FY27 | Q4 FY26 | Change | |
|---|---|---|---|
| Gross margin | 64.9% | 66.2% | -1.4 pts |
| Operating margin | 11.7% | 4.3% | +7.4 pts |
| Net margin | 4.7% | -6.5% | +11.2 pts |
| Free cash flow margin | 23.6% | 21.3% | +2.3 pts |
Every line
| Line | Q1 FY27 | Q4 FY26 | Change | % |
|---|---|---|---|---|
| Revenue | $60.1M | $63.7M | −$3.6M | -6% |
| Gross profit | $39.0M | $42.2M | −$3.2M | -8% |
| Cost of revenue | $21.1M | $21.5M | −$393K | -2% |
| Operating profit | $7.0M | $2.7M | $4.3M | +156% |
| Operating expenses | $32.0M | $39.5M | −$7.5M | -19% |
| Pre-tax earnings | $4.4M | −$1.6M | $5.9M | — |
| Other expense, net | $2.7M | $4.3M | −$1.7M | -38% |
| Research & development | $4.7M | $5.2M | −$522K | -10% |
| Sales & marketing | $9.9M | $10.1M | −$206K | -2% |
| General & admin | $17.4M | $24.1M | −$6.7M | -28% |
| Net earnings | $2.8M | −$4.1M | $7.0M | — |
| Income tax | $1.5M | $2.5M | −$1.0M | -40% |
| Depreciation & amortization | $5.6M | $5.8M | −$105K | -2% |
| Share-based compensation | $2.4M | $6.8M | −$4.4M | -65% |
| Working capital & other | $3.9M | $5.6M | −$1.7M | -30% |
| Operating cash flow | $14.7M | $14.0M | $774K | +6% |
| Free cash flow (OCF − capex) | $14.2M | $13.5M | $632K | +5% |
| Capital expenditures | $559K | $417K | $142K | +34% |
Questions
How much did Mesa Laboratories's revenue grow quarter over quarter in Q1 FY27?
Mesa Laboratories's revenue fell $3.6M (-6%) from $63.7M in Q4 FY26 to $60.1M in Q1 FY27. Gross margin 64.9% against 66.2% (-1.4 pts).